The application was described as 'finely balanced, but the report suggests that approval would be huge contribution to the area.
By Rich Wilcock
21st Feb 2023 | Healthcare
The Macclesfield-based company is setting its sights on growth with an expanded team and new products.
By Rich Wilcock
10th Feb 2023 | Healthcare
Higher corporation tax blamed for Macclesfield missing out on AstraZeneca's new manufacturing facility.
The company expects another strong performance in 2023, despite COVID vaccine demand dropping.